Triple receptor-negative breast cancer: Imaging and clinical characteristics

American Journal of Roentgenology

Volumn 199, Issue 2, 2012, Pages 458-464

  Krizmanich Conniff, Kristin M ^a   Paramagul, Chintana ^b   Patterson, Stephanie K ^b   Helvie, Mark A ^b   Roubidoux, Marilyn A ^b   Myles, Jamie D ^b   Jiang, Kiting ^b   Sabel, Michael ^b  

^a Regional Medical Imaging ^*  (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Breast cancer; Breast ultrasound; Estrogen receptor (ER); Human epidermal growth factor receptor 2 (HER2); Mammography; Progesterone receptor (PR); Triple receptor negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CALCIFICATION; BREAST DISCHARGE; BREAST EXAMINATION; CANCER GRADING; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTALGIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST CANCER;

ADULT; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, MAMMARY;

EID: 84864773461     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6096     Document Type: Article

References (13)

1. Dent R, Trudeau M, Pritchard KI, et al. Triple receptor- negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007; 13:4429-4434 (Pubitemid 47219710)
2. Dawood S, Broglio K, Esteva FJ, et al. Survival among women with triple receptor-negative breast cancer and brain metastases. Ann Oncol 2009; 20:621-627
3. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295:2492-2502 (Pubitemid 43854964)
4. Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCA1 mutations in triple negative breast cancer (BC) (abstr). J Clin Oncol 2006; 24:508
5. Yang W-T, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 2008; 111:405-410
6. Wang Y, Ikeda DM, Narasimhan B, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology 2008; 246:367-375
7. Ko E, Lee B, Kim H-A, Noh W-C, Kim M, Lee S-A. Triple receptor-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol 2010; 20:1111-1117
8. D'Orsi CJ, Mendelson, EB, Ikeda DM, et al: Breast Imaging Reporting and Data System: ACR BI-RADS-breast imaging atlas. Reston, VA: American College of Radiology, 2003
9. Lazarus E, Mainiero M, Schepps B, et al. BIRADS lexicon for US and mammography: interobserver variability and positive predictive value. Radiology 2006; 239:385-391
10. Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR 2010; 194:1160-1166
11. Collett K, Stefansson IM, Eide J, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 2005; 14:1108-1112 (Pubitemid 40656455)
12. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple receptor-negative phenotype: a population-based study from the California Cancer Registry. Cancer 2007; 109:1721-1728 (Pubitemid 46668532)
13. Foulkes W, Metcalfe K, Hanna W, et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 2003; 98:1569-1577 (Pubitemid 37238611)